Tag: Cancer: Cervical
Whether HPV Vaccination Will Prevent Cervical Cancer Unclear
Review highlights limitations of trial design; additional research needed to address uncertainties
Cervical Cancer Screening Remains Low in Women Ages 45 to 65 Years
Screening rates are insufficient to reduce cervical cancer incidence
Cervical Cancer Screening Remains Low in Women Ages 45 to 65 Years
Screening rates are insufficient to reduce cervical cancer incidence
Most HPV-Linked Cancers Due to Types Targeted by 9vHPV Vaccine
In 2012 to 2016, 92 percent of cancers attributable to HPV due to HPV types targeted by 9vHPV vaccine
DNA Methylation Classifier Predicts Progression in CIN2
For regression versus progression outcome, highest AUC was 0.735 for combination of S5, cytology
Psychologic Distress Linked to Cervical Cancer Mortality
Risk up with diagnosis of stress-related disorders or an occurrence of stressful life events around diagnosis
One Dose of HPV Vaccine May Be Sufficient in Certain Situations
One dose compared with two or three doses in preventing cervical precancer in high-coverage settings
FIGO 2018 Staging Ups Discrimination of Stage 1B Cervical Cancer
Classifying all women with positive lymph nodes into single stage yields highly variable survival rates
Higher Surgical Volume May Improve Outcomes in Cervical Cancer
Findings show radical hysterectomy at high-volume centers tied to better survival in early cervical cancer
Some Cervical Cancer Screening Strategies More Cost-Effective
Most lifetime QALYs seen with cytologic testing every three years, repeated for ASC-US
